INMB · Inmune Bio, Inc. · Suppliers & Customers
$0.89
0.00 (-0.47%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events raise substantial doubt about the Company’s ability to continue as a going concern. As a result, the Company has concluded that management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 5, 2026
Market Cap
$27.68M
Shares
30.96M
Volume · Nov 20
7246
Avg daily vol (3M)
342.92K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Supply Chain
Customers, suppliers, competitors and partners, private companies included: the ones INMB names, and the companies that name INMB.
Read supply chains in your AI or your code through MCP and the API →
Pro
See who INMB sells to, buys from and competes with
- 0 suppliers
- 0 customers
- 1 competitor
Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.
Key facts
CIK
1711754
CUSIP
45782T105
13F (30d)
70 filings
58 filers
Visit website
Investor relations